CLOs on the Move

Reckitt Benckiser

www.rb.com

 
We protect, heal and nurture in the relentless pursuit of a cleaner, healthier world. Our products reach millions of people every day, as we fight to improve global access to the highest quality hygiene, wellness and nourishment. We`re a growing community of 40,000+ diverse, talented entrepreneurs, and the driving force behind some of the world`s most loved and trusted brands. Our portfolio includes household names such as Enfamil, Nutramigen, Nurofen, Strepsils, Gaviscon, Mucinex, Durex, Lysol, Dettol, Harpic, Cillit Bang, Finish and Vanish. Hygiene, Health and Nutrition are the focus areas of our business, and the categories under which our brands ...
  • Number of Employees: 5K-10K
  • Annual Revenue: > $1 Billion
  • www.rb.com
  • 399 Interpace Parkway P.O. Box 225
    Parsippany, NJ USA 07054
  • Phone: 973.404.2600

Executives

Name Title Contact Details
Pascal Montilus
Chief Supply Chain Officer Profile
Monica Wahba
Assistant General Counsel - Global Business Solutions Profile
Justin Griner
Legal Director NA, Nutrition Profile
Eliane Setton
VP - General Counsel, Compliance Officer, Corporate Secretary, Hygiene Home, North America Profile
Tara Byrne
Associate General Counsel Profile

Similar Companies

Cardinal Analytx Solutions

Cardinal Analytx Solutions brings together distinguished innovators and leaders collaboratively advancing into new territory to substantially address one of the most pressing human and economic challenges of our time.

Dental Art Laboratory Inc

Dental Art Laboratory Inc is a Lansing, MI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Adelphi International Research

Adelphi International Research is a Doylestown, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Worldcare Limited

Worldcare Limited is a Boston, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Maverick Therapeutics

Maverick Therapeutics is pioneering the next generation of redirected T-cell targeted immunotherapies. Mavericks highly innovative platform, COBRA™, is the most advanced bispecific T-cell engaging platform in its class, designed to safely target solid tumors with highly specific and potent activity.